Articles tagged ‘’

Consultant physicians are increasingly working above and beyond their contracted hours, while the amount of time consultants have to spend with trainees is decreasing and some specialties are experiencing low levels of growth in consultant numbers, according to a census¹ conducted by the Federation of Royal Colleges of Physicians.

Rivaroxaban (Xarelto®) has become the first once-daily, fixed-dose preventative treatment for UK patients with non-valvular atrial fibrillation (AF) at risk of stroke, without the need for routine coagulation monitoring.

Up to 24,000 people with diabetes are dying each year from causes that could be avoided through better management of their condition, according to the first ever report on mortality from the National Diabetes Audit.¹

The health of European men is changing, with a reduction of 24 million men of working age (15-64) and an increase of 32 million men aged 65 and over across Europe by 2060, according to a report¹ on the health of men in Europe recently debated at Leeds Metropolitan University.